CSIMarket
 
Kiniksa Pharmaceuticals International Plc  (NASDAQ: KNSA)
 

Kiniksa Pharmaceuticals International Plc's Suppliers Performance

KNSA's Supply Chain




 
KNSA Costs vs Sales of Suppliers Growth Kiniksa Pharmaceuticals International Plc recorded an increase in cost of sales by 16.39 % year on year, relative to one quarter ago cost of sales fell by -0.71 % in Q1.

More on KNSA Suppliers



Kiniksa Pharmaceuticals International Plc recorded increase in cost of sales by 16.39 % year on year, compare to one quarter ago cost of sales fell by -0.71 % in Q1.

More on KNSA Suppliers




Kiniksa Pharmaceuticals International Plc's Comment on Supply Chain









KNSA's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Kiniksa Pharmaceuticals International Plc 6,269.73 754.05 73.06 366
SUBTOTAL 0.00 0.00 0.00 -


Sources: Kiniksa Pharmaceuticals International Plc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Kiniksa Pharmaceuticals International Plc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.